345 related articles for article (PubMed ID: 29161883)
1. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment.
Fouani L; Kovacevic Z; Richardson DR
Antioxid Redox Signal; 2019 Mar; 30(8):1096-1123. PubMed ID: 29161883
[TBL] [Abstract][Full Text] [Related]
2. The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells.
Menezes SV; Fouani L; Huang MLH; Geleta B; Maleki S; Richardson A; Richardson DR; Kovacevic Z
Carcinogenesis; 2019 Jul; 40(6):805-818. PubMed ID: 30561520
[TBL] [Abstract][Full Text] [Related]
3. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
4. Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1).
Xi R; Pun IH; Menezes SV; Fouani L; Kalinowski DS; Huang ML; Zhang X; Richardson DR; Kovacevic Z
Mol Pharmacol; 2017 May; 91(5):499-517. PubMed ID: 28275050
[TBL] [Abstract][Full Text] [Related]
5. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938
[TBL] [Abstract][Full Text] [Related]
6. Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
Verzella D; Fischietti M; Capece D; Vecchiotti D; Del Vecchio F; Cicciarelli G; Mastroiaco V; Tessitore A; Alesse E; Zazzeroni F
Curr Drug Targets; 2016; 17(3):311-20. PubMed ID: 26343112
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
Zeligs KP; Neuman MK; Annunziata CM
Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
[TBL] [Abstract][Full Text] [Related]
8. Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway.
Pantano C; Reynaert NL; van der Vliet A; Janssen-Heininger YM
Antioxid Redox Signal; 2006; 8(9-10):1791-806. PubMed ID: 16987032
[TBL] [Abstract][Full Text] [Related]
9. A pentacyclic triterpene derivative possessing polyhydroxyl ring A suppresses growth of HeLa cells by reactive oxygen species-dependent NF-κB pathway.
Huang RZ; Jin L; Wang CG; Xu XJ; Du Y; Liao N; Ji M; Liao ZX; Wang HS
Eur J Pharmacol; 2018 Nov; 838():157-169. PubMed ID: 30153443
[TBL] [Abstract][Full Text] [Related]
10. Tetrachlorobenzoquinone exhibits neurotoxicity by inducing inflammatory responses through ROS-mediated IKK/IκB/NF-κB signaling.
Fu J; Shi Q; Song X; Xia X; Su C; Liu Z; Song E; Song Y
Environ Toxicol Pharmacol; 2016 Jan; 41():241-50. PubMed ID: 26745386
[TBL] [Abstract][Full Text] [Related]
11. Redox activation of Nrf2 & NF-κB: a double end sword?
Buelna-Chontal M; Zazueta C
Cell Signal; 2013 Dec; 25(12):2548-57. PubMed ID: 23993959
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB as a potential molecular target for cancer therapy.
Lee CH; Jeon YT; Kim SH; Song YS
Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
[TBL] [Abstract][Full Text] [Related]
13. Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor kappaB are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent.
Jing Y; Yang J; Wang Y; Li H; Chen Y; Hu Q; Shi G; Tang X; Yi J
Free Radic Biol Med; 2006 Jun; 40(12):2183-97. PubMed ID: 16785032
[TBL] [Abstract][Full Text] [Related]
14. Sodium selenite induces apoptosis via ROS-mediated NF-κB signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells.
Zhang T; Zhao G; Zhu X; Jiang K; Wu H; Deng G; Qiu C
J Cell Physiol; 2019 Mar; 234(3):2511-2522. PubMed ID: 30218457
[TBL] [Abstract][Full Text] [Related]
15. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
16. Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison.
Chong SJF; Lai JXH; Eu JQ; Bellot GL; Pervaiz S
Antioxid Redox Signal; 2018 Dec; 29(16):1553-1588. PubMed ID: 29186971
[TBL] [Abstract][Full Text] [Related]
17. Glycitein induces reactive oxygen species-dependent apoptosis and G0/G1 cell cycle arrest through the MAPK/STAT3/NF-κB pathway in human gastric cancer cells.
Zang YQ; Feng YY; Luo YH; Zhai YQ; Ju XY; Feng YC; Wang JR; Yu CQ; Jin CH
Drug Dev Res; 2019 Aug; 80(5):573-584. PubMed ID: 30916421
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
[TBL] [Abstract][Full Text] [Related]
19. Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer Cells.
Jeong Y; Lim JW; Kim H
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30939781
[TBL] [Abstract][Full Text] [Related]
20. Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor.
Vaisitti T; Gaudino F; Ouk S; Moscvin M; Vitale N; Serra S; Arruga F; Zakrzewski JL; Liou HC; Allan JN; Furman RR; Deaglio S
Haematologica; 2017 Nov; 102(11):1878-1889. PubMed ID: 28860341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
